| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Silexion Therapeutics Corp | CFO and Secretary | Ordinary Shares | 50,146 | $122,356 | $2.44 | 20 Feb 2026 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| SLXN | Silexion Therapeutics Corp | 20 Feb 2026 | 1 | $0 | 4 | CFO and Secretary | 23 Feb 2026, 16:16 |
| SLXN | Biomotion Sciences | 15 Aug 2024 | 0 | $0 | 3 | EVP of Finance Affairs, CFO | 15 Aug 2024, 19:48 |